Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles.

Taylor-Cousar JL, Mall MA, Ramsey BW, McKone EF, Tullis E, Marigowda G, McKee CM, Waltz D, Moskowitz SM, Savage J, Xuan F, Rowe SM.

ERJ Open Res. 2019 Jun 17;5(2). pii: 00082-2019. doi: 10.1183/23120541.00082-2019. eCollection 2019 Apr.

2.

VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM; VX16-659-101 Study Group.

N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18.

3.

VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Keating D, Marigowda G, Burr L, Daines C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Sass LA, Tullis E, McKee CM, Moskowitz SM, Robertson S, Savage J, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Taylor-Cousar JL; VX16-445-001 Study Group.

N Engl J Med. 2018 Oct 25;379(17):1612-1620. doi: 10.1056/NEJMoa1807120. Epub 2018 Oct 18.

4.

Protease nexin-1 prevents growth of human B cell lymphoma via inhibition of sonic hedgehog signaling.

Xin X, Ding Y, Yang Y, Fu X, Zhou J, McKee CM, Muschel RJ, Gale RP, Apperley JF, Xu D.

Blood Cancer J. 2018 Feb 26;8(2):24. doi: 10.1038/s41408-018-0063-x. No abstract available.

5.

Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.

Gonnissen A, Isebaert S, Perneel C, McKee CM, Van Utterbeeck F, Lerut E, Verrill C, Bryant RJ, Joniau S, Muschel RJ, Haustermans K.

Am J Pathol. 2018 Mar;188(3):795-804. doi: 10.1016/j.ajpath.2017.11.019. Epub 2018 Jan 12.

6.

Modulating affective experience and emotional intelligence with loving kindness meditation and transcranial direct current stimulation: A pilot study.

Robinson C, Armenta M, Combs A, Lamphere ML, Garza GJ, Neary J, Wolfe JH, Molina E, Semey DE, McKee CM, Gallegos SJ, Jones AP, Trumbo MC, Al-Azzawi H, Hunter MA, Lieberman G, Coffman BA, Aboseria M, Bikson M, Clark VP, Witkiewitz K.

Soc Neurosci. 2019 Feb;14(1):10-25. doi: 10.1080/17470919.2017.1397054. Epub 2017 Oct 31.

PMID:
29067880
7.

Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer.

Gonnissen A, Isebaert S, Perneel C, McKee CM, Verrill C, Bryant RJ, Van Utterbeeck F, Lerut E, Haustermans K, Muschel RJ.

BMC Cancer. 2017 Sep 6;17(1):634. doi: 10.1186/s12885-017-3619-4.

8.

The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells.

Gonnissen A, Isebaert S, McKee CM, Muschel RJ, Haustermans K.

Int J Mol Sci. 2017 Feb 13;18(2). pii: E399. doi: 10.3390/ijms18020399.

9.

The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo.

Gonnissen A, Isebaert S, McKee CM, Dok R, Haustermans K, Muschel RJ.

Oncotarget. 2016 Dec 20;7(51):84286-84298. doi: 10.18632/oncotarget.12483.

10.

Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein.

McKee CM, Ding Y, Zhou J, Li C, Huang L, Xin X, He J, Allen JE, El-Deiry WS, Cao Y, Muschel RJ, Xu D.

Oncotarget. 2015 Feb 28;6(6):3784-96.

11.

Proteomic analysis reveals a proteolytic feedback loop in murine seminal fluid.

McKee CM, Xu D, Kessler BM, Muschel RJ.

Prostate. 2013 Sep;73(13):1427-40. doi: 10.1002/pros.22690. Epub 2013 Jun 14.

PMID:
23765702
12.

Protease nexin 1: a novel regulator of prostate cancer cell growth and neo-angiogenesis.

McKee CM, Xu D, Muschel RJ.

Oncotarget. 2013 Jan;4(1):1-2. No abstract available.

13.

Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.

McKee CM, Xu D, Cao Y, Kabraji S, Allen D, Kersemans V, Beech J, Smart S, Hamdy F, Ishkanian A, Sykes J, Pintile M, Milosevic M, van der Kwast T, Zafarana G, Ramnarine VR, Jurisica I, Mallof C, Lam W, Bristow RG, Muschel RJ.

J Clin Invest. 2012 Nov;122(11):4025-36. doi: 10.1172/JCI59348. Epub 2012 Oct 8.

14.

In amenable mortality--deaths avoidable through health care--progress in the US lags that of three European countries.

Nolte E, McKee CM.

Health Aff (Millwood). 2012 Sep;31(9):2114-22. doi: 10.1377/hlthaff.2011.0851. Epub 2012 Aug 29. Erratum in: Health Aff (Millwood). 2012 Oct;31(10):2356.

PMID:
22933419
15.

Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood.

Bjornsdottir US, Holgate ST, Reddy PS, Hill AA, McKee CM, Csimma CI, Weaver AA, Legault HM, Small CG, Ramsey RC, Ellis DK, Burke CM, Thompson PJ, Howarth PH, Wardlaw AJ, Bardin PG, Bernstein DI, Irving LB, Chupp GL, Bensch GW, Bensch GW, Stahlman JE, Karetzky M, Baker JW, Miller RL, Goodman BH, Raible DG, Goldman SJ, Miller DK, Ryan JL, Dorner AJ, Immermann FW, O'Toole M.

PLoS One. 2011;6(7):e21902. doi: 10.1371/journal.pone.0021902. Epub 2011 Jul 14.

16.

Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.

Xu D, McKee CM, Cao Y, Ding Y, Kessler BM, Muschel RJ.

Cancer Res. 2010 Sep 1;70(17):6988-98. doi: 10.1158/0008-5472.CAN-10-0242. Epub 2010 Aug 24.

17.

Measuring the health of nations: updating an earlier analysis.

Nolte E, McKee CM.

Health Aff (Millwood). 2008 Jan-Feb;27(1):58-71. doi: 10.1377/hlthaff.27.1.58. Erratum in: Health Aff (Millwood). 2008 Mar-Apr;27(2):593.

PMID:
18180480
19.
20.
21.

Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages.

Horton MR, McKee CM, Bao C, Liao F, Farber JM, Hodge-DuFour J, Puré E, Oliver BL, Wright TM, Noble PW.

J Biol Chem. 1998 Dec 25;273(52):35088-94.

22.

Consensus development methods, and their use in clinical guideline development.

Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, Marteau T.

Health Technol Assess. 1998;2(3):i-iv, 1-88. Review. No abstract available.

23.

Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments.

Rockey DC, Chung JJ, McKee CM, Noble PW.

Hepatology. 1998 Jan;27(1):86-92.

PMID:
9425922
24.

Limitations of epidemiologically based needs assessment. The case of prostatectomy.

Sanderson CF, Hunter DJ, McKee CM, Black NA.

Med Care. 1997 Jul;35(7):669-85.

PMID:
9219495
25.

Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism.

McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, Choi AM, Noble PW.

J Biol Chem. 1997 Mar 21;272(12):8013-8.

26.

Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.

McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW.

J Clin Invest. 1996 Nov 15;98(10):2403-13.

27.

Heart failure: the Cinderella of cardiology?

McKinnon ME, McKee CM.

Public Health. 1996 Nov;110(6):351-5. Review.

PMID:
8979751
28.
29.

The impact of lower urinary tract symptoms on general health status and on the use of prostatectomy.

Hunter DJ, McKee CM, Black NA, Sanderson CF.

Qual Life Res. 1995 Aug;4(4):335-41.

PMID:
7550182
30.

Health care sought and received by men with urinary symptoms, and their views on prostatectomy.

Hunter DJ, McKee CM, Black NA, Sanderson CF.

Br J Gen Pract. 1995 Jan;45(390):27-30.

31.

Urinary symptoms: prevalence and severity in British men aged 55 and over.

Hunter DJ, McKee CM, Black NA, Sanderson CF.

J Epidemiol Community Health. 1994 Dec;48(6):569-75.

32.

Appropriate indications for prostatectomy in the UK--results of a consensus panel.

Hunter DJ, McKee CM, Sanderson CF, Black NA.

J Epidemiol Community Health. 1994 Feb;48(1):58-64. Review.

33.

How can the work of junior paediatricians be reduced?

McKee CM, Priest P, Ginzler M, Black NA.

Arch Dis Child. 1991 Sep;66(9):1085-9. No abstract available.

34.

Micro-computers: availability to and use by trainees in public health medicine.

McKee CM, Tennison BR.

Public Health. 1990 May;104(3):165-9.

PMID:
2359835
35.
36.

Accident and emergency attendance rates: variation among patients from different general practices.

McKee CM, Gleadhill DN, Watson JD.

Br J Gen Pract. 1990 Apr;40(333):150-3.

37.

Effectiveness of intradermal hepatitis B immunization of hospital staff.

McKee CM, Duke P, McEvoy MB, Kelsey MC.

Int J STD AIDS. 1990 Jan;1(1):32-4.

PMID:
2151564
38.

Cold at heart.

McKee CM.

Lancet. 1989 Sep 2;2(8662):564-5. No abstract available.

PMID:
2570267
39.

Can medical audit be implemented by 1991?

McKee CM.

Postgrad Med J. 1989 Sep;65(767):645-9. No abstract available.

40.

Medical audit: a review.

McKee CM, Lauglo M, Lessof L.

J R Soc Med. 1989 Aug;82(8):474-8. Review. No abstract available.

41.

Deaths in winter: can Britain learn from Europe?

McKee CM.

Eur J Epidemiol. 1989 Jun;5(2):178-82.

PMID:
2767225
42.

Hepatitis B immunisation in northern Ireland: an epidemiological and economic analysis.

McKee CM, Dinsmore WW.

Ir Med J. 1989 Jun;82(2):83-7. Review.

PMID:
2503462
43.

Improving clinical practice.

Black NA, McKee CM.

J R Soc Med. 1988 Nov;81(11):621-2. No abstract available.

44.

Attitudes to a hospital based terminal care scheme.

McKee CM, Rajaratnam G, Lessof L.

Postgrad Med J. 1988 Sep;64(755):678-80.

45.
46.

Charges for preventive services: what difference will it make?

Curson JA, McKee CM.

Lancet. 1987 Dec 26;2(8574):1528. No abstract available.

PMID:
2892088
47.

Medical and social aspects of qat in Yemen: a review.

McKee CM.

J R Soc Med. 1987 Dec;80(12):762-5. Review. No abstract available.

48.

Maintaining percutaneous nephrostomy catheters and the management of intractable leakage at the insertion site.

McKee CM, Sherr C.

J Enterostomal Ther. 1987 May-Jun;14(3):125-8. No abstract available.

PMID:
3647053
49.

Diversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value.

McMillan SA, Alderdice JM, McKee CM, Dawson AT, Callender ME, Fulton TT, Haire M.

J Clin Pathol. 1987 Feb;40(2):232-6.

50.

Deaths from amenable causes.

McKee CM, Rajaratnam G.

Lancet. 1986 Mar 29;1(8483):734-5. No abstract available.

PMID:
2870238

Supplemental Content

Loading ...
Support Center